LURASIDONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lurasidone Hydrochloride, and what generic alternatives are available?
Lurasidone Hydrochloride is a drug marketed by Accord Hlthcare, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Aurobindo Pharma Ltd, Avet Lifesciences, Dr Reddys, Invagen Pharms, Lupin Ltd, Macleods Pharms Ltd, MSN, Slate Run Pharma, Sun Pharm, Teva Pharms Usa, Torrent, Watson Labs Teva, and Zydus Pharms. and is included in seventeen NDAs.
The generic ingredient in LURASIDONE HYDROCHLORIDE is lurasidone hydrochloride. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the lurasidone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lurasidone Hydrochloride
A generic version of LURASIDONE HYDROCHLORIDE was approved as lurasidone hydrochloride by ACCORD HLTHCARE on January 3rd, 2019.
Summary for LURASIDONE HYDROCHLORIDE
Recent Clinical Trials for LURASIDONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
First Affiliated Hospital of Zhejiang University | Phase 4 |
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Phase 4 |
Bracket, Inc. | Phase 2/Phase 3 |
Pharmacology for LURASIDONE HYDROCHLORIDE
Drug Class | Atypical Antipsychotic |
Medical Subject Heading (MeSH) Categories for LURASIDONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for LURASIDONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for LURASIDONE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LATUDA | Tablets | lurasidone hydrochloride | 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg | 200603 | 14 | 2014-10-28 |